TOURISE and Oxford Economics Release White Paper Charting Tourism’s Path to Resilience and Stability Amid Global Volatility November 10, 2025 International travel projected to exceed 2 billion arrivals by 2030, despite global economic and geopolitical uncertainty Strategic investment in infrastructure, policy, and accessibility key to unlocking continued growth
Rachel Reeves concedes manifesto pledges may be dropped November 10, 2025 Chancellor Rachel Reeves has suggested that Labour manifesto commitments will be ditched amid a “significantly worse” economic inheritance than expected last year. In an interview with the BBC, Reeves said she would prefer to increase government spending on infrastructure rather than cut taxes for Britons. When asked whether the government would stick to manifesto commitments, [...]
ReNew Announces Results for the Second Quarter for Fiscal Year 2026 (Q2 FY26), Ended September 30, 2025; Reports 84% Net Profit Increase YOY in H1 FY2026 November 10, 2025 ReNew Energy Global Plc (“ReNew” or “the Company”) (Nasdaq: RNW, RNWWW), a leading decarbonization solutions company, today announced its unaudited consolidated IFRS results for the three-month period ended September 30, 2025. Operating Highlights: As of September 30, 2025, the Company’s portfolio consisted of ~18.5 GWs (+1.1 GWh BESS), compared to ~15.6 GWs as of September [...]
London set for new 15,000-capacity arena in boost for capital November 10, 2025 The capital is set to gain a 15,000-capacity basketball arena after studies surrounding a new stadium for the London Lions concluded their opening phase. The custom-built, multi-purpose stadium could stage as many as 40 basketball games per season as well as hundreds of cultural events. A London Lions feasibility study conducted in conjunction with The [...]
Reeves set to bring in US-style whistleblowing pay for HMRC November 10, 2025 Chancellor Rachel Reeves is set to reveal a US-style whistleblower scheme to combat large-scale tax fraud. Later this month, HMRC is expected to launch a reward scheme, according to the Financial Times, which could pay informants as much as 30 per cent of any taxes collected as a result of tip-offs. The new US-style incentive [...]
Autumn Budget: How could Rachel Reeves change salary sacrifice rules? November 10, 2025 Salary sacrifice schemes have allowed Brits earning more than £100,000 to avoid high taxes since the 1970s. While a pay rise can be lucrative for some employees, for others being dragged over the £100,000 threshold can be financially damaging, particularly for parents of young children who risk having their free childcare hours pulled away and [...]
The City’s first Lady Mayor is a symbol of progress November 10, 2025 The historic appointment of Dame Susan Langley as the City of London’s first “Lady Mayor” is a powerful symbol of progress, but women still face deep, persistent systemic barriers to equality in business, says Natasha Frangos On Saturday, Dame Susan Langley made history not as the first woman to lead the City of London but [...]
Rachel Reeves eyes tax raid on dividends November 10, 2025 Chancellor Rachel Reeves is set to increase the tax rate on dividends at this year’s Budget, it has been reported, adding to speculation that investors and business owners will be targeted to fill a £30bn fiscal hole. An increase on basic, higher and additional rates of dividend taces could make up around £2bn in extra [...]
Guinness owner Diageo shares rocket after appointment of ‘Drastic Dave’ November 10, 2025 Shares in FTSE 100 drinks giant Diageo have rocketed after the appointment of a new chief executive with an impressive turnaround record. News of the appointment of retail and consumer goods veteran Sir Dave Lewis saw shares in the struggling giant rise 6.8 per cent in early morning trading to 1,845p, rebounding from their sharp [...]
Almirall’s 2025 9M Results November 10, 2025 Almirall continues its sustained growth trajectory in 9M 2025 - delivering 12.8% net sales growth, strong dermatology performance, solid commercial execution in Europe, and further pipeline progress Sustained strong growth momentum with 12.8% Net Sales YoY increase to a total of €820.7 MM, with biologics continuing to deliver double-digit growth YoY and dermatology sales in Europe increasing 24.5% YoY further advancing Almirall´s leadership in medical dermatology. EBITDA increase of 27.1% YoY in line with expectations, reaching a total of €180.7 MM. On track to meet 2025 guidance driven by biologics growth and operational strength. Performance continues to be primarily driven by the biologics portfolio, with Ilumetri® net sales increasing 12.1% YoY (total of €170.9 MM), and Ebglyss® net sales of €75.5 MM – reflecting a more than 3x increase YoY as European markets are ramping up after launch. Solid performance of the broad dermatology product portfolio with Wynzora® growing 32.4% YoY to a total of €25.4 MM, and Klisyri® growing 22.6% YoY to a total of €20.1 MM, further enhancing Almirall’s position as trusted partner for patients and dermatologists. Continued R&D pipeline progress includes the start of the phase II study of the anti-IL-1RAP mAb, and plan to initiate three additional proof-of-concept studies over the coming 9 to 12 months.